Evidence map›Paper›PMID 25664343›Full record

ArticleJacobs journal of allergy and immunology2014

Immune response to immunodominant Mycobacterium tuberculosis antigen ESAT-6 derived peptide is HLA-haplotype dependent.

Michele Smart, Marshall Behrens, Luckey David, Catherine Conway, Veena Taneja

Open access · greenAbstract read
In one paragraph

Article in Jacobs journal of allergy and immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Applications of humanized mice inMolecular medicine reports · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Michele SmartDepartment of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
Marshall BehrensDepartment of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN 55905.
Luckey David
Catherine Conway
Veena Taneja
Mayo Clinic · USMayo Clinic in Arizona · US

Funding

IMMUNOGENETICS OF COLLAGEN-INDUCED ARTHRITIS IN MICER01AR030752 · NIAMS · MAYO CLINIC ROCHESTER · PI DAVID, CHELLA S, TANEJA, VEENA · 1987 to 2014
$4.3M
Role of B cells in pathogenesis of Collagen-induced Arthritis in Humanized MiceR01AI075262 · NIAID · MAYO CLINIC ROCHESTER · PI TANEJA, VEENA · 2009 to 2012
$1.2M
Immunogenetics of Collagen Induced Arthritis in MiceR56AR030752 · NIAMS · MAYO CLINIC ROCHESTER · PI DAVID, CHELLA S, TANEJA, VEENA · 2009 to 2009
$325k
NIAID NIH HHS R01 AI075262NIAMS NIH HHS R01 AR030752NIAMS NIH HHS R56 AR030752
6 · The paper itself

Abstract

The antigenic proteins of Mycobacterium tuberculosis (Mtb) have been defined. We used synthetic peptides of secreted antigens, early secreted antigenic target 6 (ESAT-6) and cultural filtrate protein-10 (CFP-10), of Mtb and characterized the immune response in context of HLA genes. Humanized mice lacking endogenous class II molecules but expressing various human DR and DQ HLA transgenes singly or as a haplotype were used to study the HLA-mediated immune response to peptides. Our observations showed that the overall response to the promiscuous ESAT-6 31-45 peptide may be dependent on the HLA haplotype rather than a single DR or DQ molecule. Further, our data showed that HLA transgenes generated a highly variable TH response to this promiscuous peptide. This provides an explanation for the variability of the bacillus Calmette-Guerin (BCG) vaccine. Our data highlights the use of HLA transgenic mice for determining the pathogenicity or therapeutic nature of a peptide in the context of HLA alleles.

Indexed as

CFP-10HLAhumanized mice ESAT-6Tuberculosis

Identifiers

PMID25664343
PMCPMC4316384
OpenAlexW2185391249

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.